Share Capital (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
| Disclosure of share capital, reserves and other equity interest [Abstract] |
|
| Schedule of Common Stock Outstanding Roll Forward |
| | | | | | | | | | Number of Shares | Amount | | Outstanding at December 31, 2023 | 396,956,984 | | $3,738.6 | | | Shares issued through: | | | Argonaut acquisition (Note 6) | 20,423,051 | | 360.1 | | | Share-based compensation plans | 1,006,149 | | 8.6 | | Orford acquisition (Note 10) | 908,689 | | 13.3 | | | Flow-through share financing (ii) | 451,990 | | 6.5 | | DRIP (iii) | 349,088 | | 5.8 | | ESPP (iv) | 401,537 | | 6.3 | | | Exercise of Manitou and Orford warrants and stock options | 88,308 | | 1.4 | | | Cancellation of unexchanged shares | (220,745) | | (2.1) | | | Outstanding at December 31, 2024 | 420,365,051 | | $4,138.5 | | | Shares issued through: | | | | Share-based compensation plans | 411,984 | | 4.5 | | | | | DRIP (iii) | 90,767 | | 2.6 | | ESPP (iv) | 252,730 | | 6.6 | | | Exercise of Orford replacement stock options | 67,141 | | 1.5 | Shares repurchased and cancelled (i) | (1,326,929) | | (13.1) | | | Outstanding at December 31, 2025 | 419,860,744 | | $4,140.6 | |
|
| Disclosure of number and weighted average exercise prices of share options |
The following is a continuity of the changes in the number of stock options outstanding: | | | | | | | | | | Number | Weighted average exercise price (CAD$) | | Outstanding at December 31, 2023 | 2,766,377 | | $9.32 | | | Granted | 471,177 | | 16.07 | | | Exercised | (1,006,149) | | 7.94 | | | | | | Outstanding at December 31, 2024 | 2,231,405 | | $11.37 | | | Granted | 275,485 | | 33.59 | | | Exercised | (411,984) | | 10.75 | | | Forfeited | (55,072) | | 14.27 | | | Outstanding at December 31, 2025 | 2,039,834 | | $14.43 | |
|
| Weighted average fair value assumptions used in the Black-Scholes valuation for stock options |
The following table presents the weighted average fair value assumptions used in the Black-Scholes valuation: | | | | | | | | | | For options granted in the year ended: | December 31, 2025 | December 31, 2024 | | Weighted average share price at grant date (CAD$) | $33.59 | | $16.07 | | | Average risk-free rate | 2.46 | % | 3.77 | % | | Average expected dividend yield | 0.43 | % | 0.78 | % | | Expected stock price volatility (based on historical volatility) | 37 | % | 40 | % | | Expected life of option (months) | 42 | 42 | | Weighted average per share fair value of stock options granted (CAD$) | $9.50 | $5.08 |
|
| Disclosure of number and weighted average remaining contractual life of outstanding share options |
Stock options outstanding and exercisable as at December 31, 2025: | | | | | | | | | | | | | | | | | | | | | | | | | | Outstanding | | Exercisable | | Range of exercise prices (CAD$) | | Number of options | Weighted average exercise price (CAD$) | Weighted average remaining contractual life (years) | | Number of options | Weighted average exercise price (CAD$) | | $6.58 - $7.00 | | 10,167 | | 6.58 | | 0.20 | | 10,167 | | 6.58 | | | $7.01 - $8.00 | | 283,745 | | 7.63 | | 1.02 | | 283,745 | | 7.63 | | | $8.01 - $11.00 | | 772,618 | | 9.46 | | 2.57 | | 772,618 | | 9.46 | | | $11.01 - $15.00 | | 292,522 | | 14.05 | | 4.18 | | 160,052 | | 14.05 | | | $15.01 - $23.83 | | 405,297 | | 16.09 | | 5.17 | | 106,961 | | 16.15 | | | $23.84 - $36.72 | | 275,485 | | 33.59 | | 6.18 | | — | | — | | | | 2,039,834 | | $14.43 | | 4.09 | | 1,333,543 | | $10.14 | |
|
| Stock options outstanding and exercisable by range of exercise prices |
Stock options outstanding and exercisable as at December 31, 2025: | | | | | | | | | | | | | | | | | | | | | | | | | | Outstanding | | Exercisable | | Range of exercise prices (CAD$) | | Number of options | Weighted average exercise price (CAD$) | Weighted average remaining contractual life (years) | | Number of options | Weighted average exercise price (CAD$) | | $6.58 - $7.00 | | 10,167 | | 6.58 | | 0.20 | | 10,167 | | 6.58 | | | $7.01 - $8.00 | | 283,745 | | 7.63 | | 1.02 | | 283,745 | | 7.63 | | | $8.01 - $11.00 | | 772,618 | | 9.46 | | 2.57 | | 772,618 | | 9.46 | | | $11.01 - $15.00 | | 292,522 | | 14.05 | | 4.18 | | 160,052 | | 14.05 | | | $15.01 - $23.83 | | 405,297 | | 16.09 | | 5.17 | | 106,961 | | 16.15 | | | $23.84 - $36.72 | | 275,485 | | 33.59 | | 6.18 | | — | | — | | | | 2,039,834 | | $14.43 | | 4.09 | | 1,333,543 | | $10.14 | |
|
| Continuity of the changes in the number of other long-term incentive plans (LTIP) outstanding |
The following is a continuity of the changes in the number of other long-term incentive plans ("LTI") outstanding for the years ended December 31, 2025 and 2024: | | | | | | | | | | | | | | Restricted share units ("RSU") | | Deferred share units ("DSU") | Performance share units ("PSU") | | Outstanding units, December 31, 2023 | 1,911,738 | | | 1,013,234 | | 1,159,288 | | | Granted | 719,978 | | | 93,546 | | 348,474 | | | Forfeited | (195,159) | | | — | | (63,254) | | | Settled | (524,965) | | | — | | (412,713) | | | Outstanding units, December 31, 2024 | 1,911,592 | | | 1,106,780 | | 1,031,795 | | | Granted | 397,329 | | | 56,947 | | 194,945 | | | Forfeited/expired | (151,915) | | | — | | — | | | Settled | (641,670) | | | (436,264) | | (399,966) | | | Outstanding units, December 31, 2025 | 1,515,336 | | | 727,463 | | 826,774 | |
|
| Schedule of Earnings (loss) per share |
| | | | | | | | | | | | | | | | | | | | | | For the years ended | | | | December 31, 2025 | December 31, 2024 | | Net earnings | | | $885.8 | | $284.3 | | | Weighted average number of common shares outstanding (in thousands) | | | 420,444 | | 408,165 | | | Basic earnings per share | | | $2.11 | | $0.70 | | | | | | | | Dilutive effect of potential common share equivalents (in thousands) | | | 2,218 | | 2,381 | | | | | | | | Diluted weighted average number of common shares outstanding (in thousands) | | | 422,662 | | 410,546 | | | Diluted earnings per share | | | $2.10 | | $0.69 | |
| | | | | | | | | | | | Share units excluded from calculation of diluted earnings per share for the years ended: | | (in thousands) | | | December 31, 2025 | December 31, 2024 | | Stock options | | | — | | 5 | | | | | | | | | | | |
|
| Schedule of share-based compensation expense |
The impact of mark-to-market adjustments on the share-based compensation expense recognized in the Consolidated Statements of Comprehensive Income arising from the change in the Company's share price for the year ended December 31, 2025 and 2024 was as follows:
| | | | | | | | | | | | | For the years ended | | | | December 31, 2025 | December 31, 2024 | | | | | | Increase in share-based compensation expense due to mark-to-market adjustments (1) | | | $41.8 | | $16.2 | |
(1) Of the total increase in share-based compensation expense due to mark-to market adjustments, $10.1 million was included in cost of sales for the year ended December 31, 2025 (2024 - $nil).
|